Cancer screening policy in Hungary
Corresponding Author
Zsuzsanna Kívés
Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, Hungary
Correspondence to: Zsuzsanna Kívés, Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Mária St. 3-5, H-7623, Pécs, Hungary, Tel.: +36-72/251-146, E-mail: [email protected]Search for more papers by this authorKrisztina Juhász
Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, Hungary
Department of Public Health, Baranya County Government Office, Pécs, Hungary
Search for more papers by this authorTímea Csákvári
Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, Hungary
Search for more papers by this authorIstván Ágoston
Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, Hungary
Search for more papers by this authorDóra Endrei
Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, Hungary
Clinical Center, University of Pécs, Pécs, Hungary
Search for more papers by this authorCorresponding Author
Zsuzsanna Kívés
Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, Hungary
Correspondence to: Zsuzsanna Kívés, Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Mária St. 3-5, H-7623, Pécs, Hungary, Tel.: +36-72/251-146, E-mail: [email protected]Search for more papers by this authorKrisztina Juhász
Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, Hungary
Department of Public Health, Baranya County Government Office, Pécs, Hungary
Search for more papers by this authorTímea Csákvári
Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, Hungary
Search for more papers by this authorIstván Ágoston
Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, Hungary
Search for more papers by this authorDóra Endrei
Institute for Health Insurance, Faculty of Health Sciences, University of Pécs, Pécs, Hungary
Clinical Center, University of Pécs, Pécs, Hungary
Search for more papers by this authorConflict of interest: None of the authors has any conflict of interest.
References
- 1 Basu P, Ponti A, Anttila A, et al. Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report. Int J Cancer 2018; 142: 44–56.
- 2 Péntek Z, Juhász B, Futár R, et al. Breast cancer screening with mammography and clinical methods. Magyar Radiológia 1972; 24: 24–31.
- 3 Tabár L, Kádas I, Márton Z, et al. The significance of mammography, galactography, and pneumocystography in detecting occult carcinomas of the breast. Surg Gynecol Obstet 1973; 137: 965–70.
- 4 Péntek Z, Bakó B, Szentgáli G, et al. Mammographic mass examinations for breast cancer among rural population selected via physical examination and epidemiologic questionnaire. Rontgenblatter 1978; 31: 173–9.
- 5 Tabar L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the breast cancer screening working group of the Swedish National Board of Health and Welfare. Lancet 1985; 1: 829–32.
- 6 Liszka G, Petrányi A, Udvarhelyi N, et al. Morphological parameters of breast cancers detected by mammography with and without organized screening; a comparative study. Orv Hetil 1999; 140: 1533–6.
- 7 Boncz I. Organized nationwide breast cancer screening programme was introduced in Hungary in 2002. Swiss Med Wkly 2006; 136: 328.
- 8 Boncz I, Sebestyen A, Dobrossy L, et al. The organization and results of first screening round of the Hungarian nationwide organised breast cancer screening programme. Ann Oncol 2007; 18: 795–9.
- 9 Döbrőssy L, Bodó M, Sugár J. Cytological mass screening, its current status and future prospects. Orv Hetil 1977; 118: 2121–34.
- 10 Boncz I, Sebestyen A. Economy and mortality in Eastern and Western Europe between 1945–1990: the largest medical trial of history. Int J Epidemiol 2006; 35: 796–7.
- 11 Bodó M, Döbrőssy L, Liszka G, et al. Cancer screening in Hungary: World Bank supported model programs. Orv Hetil 1997; 138: 1801–4.
- 12 Boncz I. Prevention of cervical cancer in low-resource settings. JAMA 2006; 295: 1248.
- 13 Kovács A, Döbrőssy L, Budai A, et al. Cervical screening in Hungary: why does the „English model” work but the “Hungarian model” does not? Eur J Gynaecol Oncol 2008; 29: 5–9.
- 14 Boncz I, Sebestyen A, Ember I. Organized, nationwide cervical cancer screening programme in Hungary. Gynecol Oncol 2007; 106: 272–3.
- 15 Vajda R, Árváné Egri C, Kovács A, et al. Assessment of the pilot program for cervical cancer screening by health visitors. Orv Hetil 2017; 158: 461–7.
- 16 Vajda R, Árváné Egri C, Kovács A, et al. Quality and performance indicators of the pilot program for cervical cancer screening by health visitors. Magy Onkol 2017; 61: 361–7.
- 17 Ottó S, Döbrossy L. Screening for colorectal cancer with immunological FOBT. Br J Cancer 2004; 90: 1871–2.
- 18 Csonka C, Molnár C, Németh M, et al. Results of and experiences with colorectal screening in town Ajka. Magy Onkol 2004; 48: 29.
- 19 Horváthné Kívés Z, Vajda R, Kovács A, et al. Experiences and attitudes related to screening of patients attended on a colorectal screening pilot program in Hungary. Value Health 2016; 19: A619.
- 20 Boncz I, Sebestyén A, Döbrossy L, et al. The role of immunochemical testing for colorectal cancer. Lancet Oncol 2006; 7: 363–4.
- 21 Boncz I, Sebestyen A, Pinter I, et al. Age-group specific gap between treatment cost of and mortality due to breast and colorectal cancer. JCO 2007; 25: 4501–2.
- 22Decree No. 51/1997 (XII. 18.) NM of the Minister of Welfare on Preventive and Early Diagnostic Services that Can be Utilized in the Frame of Social Health Insurance System and on the Certification of Participation in Screening Programmes
- 23
Oberfrank F. The role of the national health insurance fund administration in the development of health economics and health technology assessment in Hungary. Value Health Reg Issues 2017; 4: 6–7.
10.1016/j.vhri.2014.02.011 Google Scholar
Citing Literature
